nach oben

Erschienen in:

01.08.2020 | Clinical study

Combination hormone therapy increases risk of breast cancer

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Although use of conjugated equine estrogen (CEE) appears to reduce the risk of breast cancer in postmenopausal women who have undergone hysterectomy, combination therapy with CEE plus medroxyprogesterone acetate (MPA) appears to increase the risk of breast cancer in postmenopausal women with an intact uterus. These were findings of an analysis of long-term follow-up data from two Women's Health Initiative (WHI) trials published in JAMA.¹ …

1. Chlebowski RT, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials Journal of the American Medical Association 324: 369-38, No. 4, 28 Jul 2020. Available from: URL: https://doi.org/10.1001/jama.2020.9482

2. Minami CA, et al. Menopausal Hormone Therapy and Long-term Breast Cancer Risk Journal of the American Medical Association 324: 347-349, No. 4, 28 Jul 2020. Available from: URL: https://doi.org/10.1001/jama.2020.9620

Titel: Combination hormone therapy increases risk of breast cancer
Publikationsdatum: 01.08.2020
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-020-81641-2

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Combination hormone therapy increases risk of breast cancer

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2020

Health Canada provides update on status of ranitidine

Other adverse reaction research

Topiramate

Fluorouracil/oxaliplatin/tipiracil/trifluridine

Antineoplastics

Enoxaparin sodium